- Home
- PNNT vs EYPT Comparison
PNNT vs EYPT Comparison
Compare PNNT & EYPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PNNT
- EYPT
- Stock Information
- Founded
- PNNT 2007
- EYPT 1987
- Country
- PNNT United States
- EYPT United States
- Employees
- PNNT N/A
- EYPT N/A
- Industry
- PNNT Finance: Consumer Services
- EYPT Biotechnology: Laboratory Analytical Instruments
- Sector
- PNNT Finance
- EYPT Industrials
- Exchange
- PNNT Nasdaq
- EYPT Nasdaq
- Market Cap
- PNNT 462.3M
- EYPT 484.4M
- IPO Year
- PNNT 2007
- EYPT 2005
- Fundamental
- Price
- PNNT $6.71
- EYPT $8.25
- Analyst Decision
- PNNT Sell
- EYPT Strong Buy
- Analyst Count
- PNNT 3
- EYPT 8
- Target Price
- PNNT $5.88
- EYPT $24.29
- AVG Volume (30 Days)
- PNNT 491.5K
- EYPT 895.1K
- Earning Date
- PNNT 05-12-2025
- EYPT 05-07-2025
- Dividend Yield
- PNNT 14.31%
- EYPT N/A
- EPS Growth
- PNNT N/A
- EYPT N/A
- EPS
- PNNT 0.73
- EYPT N/A
- Revenue
- PNNT $138,371,000.00
- EYPT $56,042,000.00
- Revenue This Year
- PNNT N/A
- EYPT N/A
- Revenue Next Year
- PNNT N/A
- EYPT N/A
- P/E Ratio
- PNNT $9.19
- EYPT N/A
- Revenue Growth
- PNNT N/A
- EYPT 12.04
- 52 Week Low
- PNNT $5.72
- EYPT $3.91
- 52 Week High
- PNNT $8.04
- EYPT $13.99
- Technical
- Relative Strength Index (RSI)
- PNNT 52.48
- EYPT 72.87
- Support Level
- PNNT $6.60
- EYPT $5.46
- Resistance Level
- PNNT $6.76
- EYPT $8.36
- Average True Range (ATR)
- PNNT 0.13
- EYPT 0.57
- MACD
- PNNT -0.00
- EYPT 0.24
- Stochastic Oscillator
- PNNT 56.86
- EYPT 96.21
About PNNT PennantPark Investment Corporation
Pennant Park Investment Corp is a closed-end, non-diversified investment company. Its investment objective is to generate current income and capital appreciation also seeking to preserve capital through debt and equity investments. The company focuses on investing in United States middle-market companies that offer attractive risk-reward to investors and to create a diversified portfolio that includes senior secured debt, mezzanine debt, and equity investments. It generates majority of its revenue from interest and dividends received from investments made.
About EYPT EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.